Eurofins Discovery Acquires CALIXAR, Expanding Integrated Drug Discovery Capabilities and Expertise

April 6, 2023

CALIXAR is proud to be part of Eurofins Discovery and Eurofins DiscoverX® and supports their strategy to be the partner of choice to the pharmaceutical and biotech industry.

Share this post

Secure and boost
your discovery programs

Starting from native material or recombinant systems, we succeed with all types of proteins: Kinases, Phosphatases, Ubiquitins, Epigenetic Proteins, GPCRs, Ion Channels, Transporters, Receptors and Viral Proteins.